Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders

US Patent 8143220 · Granted Mar 27, 2012

Estimated economic value: $490,000

Assignee

Inventors

View full patent text on Google Patents →